BlackRock’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $227M | Buy |
6,256,145
+97,879
| +2% | +$3.56M | ﹤0.01% | 1541 |
|
2025
Q1 | $223M | Sell |
6,158,266
-378,251
| -6% | -$13.7M | ﹤0.01% | 1529 |
|
2024
Q4 | $275M | Buy |
6,536,517
+707,669
| +12% | +$29.8M | 0.01% | 1466 |
|
2024
Q3 | $324M | Buy |
5,828,848
+225,496
| +4% | +$12.5M | 0.01% | 1368 |
|
2024
Q2 | $230M | Buy |
5,603,352
+367,614
| +7% | +$15.1M | 0.01% | 1517 |
|
2024
Q1 | $244M | Sell |
5,235,738
-2,662
| -0.1% | -$124K | 0.01% | 1505 |
|
2023
Q4 | $251M | Buy |
5,238,400
+159,191
| +3% | +$7.61M | 0.01% | 1489 |
|
2023
Q3 | $181M | Buy |
5,079,209
+12,182
| +0.2% | +$434K | 0.01% | 1589 |
|
2023
Q2 | $234M | Buy |
5,067,027
+193,671
| +4% | +$8.93M | 0.01% | 1468 |
|
2023
Q1 | $195M | Buy |
4,873,356
+536,513
| +12% | +$21.5M | 0.01% | 1550 |
|
2022
Q4 | $201M | Buy |
4,336,843
+409,204
| +10% | +$19M | 0.01% | 1522 |
|
2022
Q3 | $163M | Buy |
3,927,639
+330,055
| +9% | +$13.7M | 0.01% | 1623 |
|
2022
Q2 | $215M | Buy |
3,597,584
+156,913
| +5% | +$9.36M | 0.01% | 1468 |
|
2022
Q1 | $250M | Sell |
3,440,671
-43,981
| -1% | -$3.19M | 0.01% | 1496 |
|
2021
Q4 | $293M | Buy |
3,484,652
+34,099
| +1% | +$2.87M | 0.01% | 1449 |
|
2021
Q3 | $311M | Sell |
3,450,553
-41,388
| -1% | -$3.73M | 0.01% | 1366 |
|
2021
Q2 | $333M | Sell |
3,491,941
-1,970,244
| -36% | -$188M | 0.01% | 1377 |
|
2021
Q1 | $622M | Buy |
5,462,185
+174,709
| +3% | +$19.9M | 0.02% | 824 |
|
2020
Q4 | $732M | Buy |
5,287,476
+478,279
| +10% | +$66.2M | 0.02% | 662 |
|
2020
Q3 | $395M | Sell |
4,809,197
-101,469
| -2% | -$8.34M | 0.01% | 884 |
|
2020
Q2 | $384M | Buy |
4,910,666
+347,135
| +8% | +$27.2M | 0.02% | 873 |
|
2020
Q1 | $203M | Sell |
4,563,531
-169,553
| -4% | -$7.53M | 0.01% | 1160 |
|
2019
Q4 | $202M | Buy |
4,733,084
+107,877
| +2% | +$4.61M | 0.01% | 1475 |
|
2019
Q3 | $198M | Buy |
4,625,207
+208,992
| +5% | +$8.94M | 0.01% | 1410 |
|
2019
Q2 | $280M | Sell |
4,416,215
-329,148
| -7% | -$20.9M | 0.01% | 1174 |
|
2019
Q1 | $329M | Buy |
4,745,363
+268,551
| +6% | +$18.6M | 0.01% | 1046 |
|
2018
Q4 | $195M | Buy |
4,476,812
+123,409
| +3% | +$5.37M | 0.01% | 1329 |
|
2018
Q3 | $332M | Sell |
4,353,403
-35,947
| -0.8% | -$2.74M | 0.01% | 1073 |
|
2018
Q2 | $337M | Buy |
4,389,350
+158,723
| +4% | +$12.2M | 0.02% | 1024 |
|
2018
Q1 | $216M | Buy |
4,230,627
+498,740
| +13% | +$25.4M | 0.01% | 1301 |
|
2017
Q4 | $173M | Sell |
3,731,887
-30,197
| -0.8% | -$1.4M | 0.01% | 1481 |
|
2017
Q3 | $200M | Buy |
3,762,084
+264,493
| +8% | +$14.1M | 0.01% | 1334 |
|
2017
Q2 | $217M | Buy |
3,497,591
+330,911
| +10% | +$20.6M | 0.01% | 1233 |
|
2017
Q1 | $215M | Buy |
3,166,680
+3,163,586
| +102,249% | +$214M | 0.01% | 1220 |
|
2016
Q4 | $218K | Sell |
3,094
-1,150
| -27% | -$81K | ﹤0.01% | 2041 |
|
2016
Q3 | $301K | Buy |
4,244
+271
| +7% | +$19.2K | ﹤0.01% | 1908 |
|
2016
Q2 | $194K | Buy |
3,973
+1,467
| +59% | +$71.6K | ﹤0.01% | 2084 |
|
2016
Q1 | $159K | Sell |
2,506
-34,892
| -93% | -$2.21M | ﹤0.01% | 1752 |
|
2015
Q4 | $4.2M | Sell |
37,398
-4,956
| -12% | -$556K | 0.01% | 877 |
|
2015
Q3 | $4.08M | Buy |
42,354
+41,447
| +4,570% | +$3.99M | 0.01% | 831 |
|
2015
Q2 | $93K | Buy |
907
+740
| +443% | +$75.9K | ﹤0.01% | 1774 |
|
2015
Q1 | $10K | Hold |
167
| – | – | ﹤0.01% | 2708 |
|
2014
Q4 | $7K | Hold |
167
| – | – | ﹤0.01% | 2922 |
|
2014
Q3 | $9K | Hold |
167
| – | – | ﹤0.01% | 2756 |
|
2014
Q2 | $7K | Sell |
167
-10,700
| -98% | -$449K | ﹤0.01% | 2962 |
|
2014
Q1 | $531K | Buy |
+10,867
| New | +$531K | ﹤0.01% | 1308 |
|